Pnc Financial Services Group, Inc. Harvard Bioscience Inc Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,544 shares of HBIO stock, worth $4,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,544
Previous 7,544
-0.0%
Holding current value
$4,903
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HBIO
# of Institutions
63Shares Held
22.3MCall Options Held
54KPut Options Held
0-
Amh Equity LTD4.05MShares$2.63 Million2.46% of portfolio
-
Weber Capital Management LLC /Adv San Francisco, CA3.2MShares$2.08 Million2.02% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.85 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.05MShares$1.33 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.25 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $27.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...